Proteome and phosphoproteome changes associated with prognosis in acute myeloid leukemia
M. d. C. Hernandez-Valladares, E. Aasebo, F. S. Berven, S. Bartaula-Brevik, T. Stokowy, R. Hovland, M. Vaudel, S. O. Doskeland, E. McCormack, T. S. Batth, J. V. Olsen, O. Bruserud, F. Selheim
This study identifies proteome and phosphoproteome changes associated with AML relapse using patient samples and validates them with kinase inhibitors.
bioRxiv · Oct 10, 2019Cancer Biology